Efficacy of Diaphragmatic Proprioceptive Neuromuscular Facilitation on Functional Capacity and Pulmonary Function in Heavy Twenties Smokers
NCT ID: NCT07003893
Last Updated: 2025-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2025-07-05
2025-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes
NCT05610514
Identifying Treatments to Motivate Smokers to Quit
NCT01122238
Effects of E-cigarette Use on Health
NCT06610838
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
NCT06053567
Effect of Resistance Training on Tobacco-Related Cardiovascular Disease Risk
NCT01705951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
perform exercises using aerobic exercises only
Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises
Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises
Experimental group
perform diaphragmatic proprioceptive neuromuscular facilitation and aerobic exercise
Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises
Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises
Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have been smoking for 1 to 3 years.
* Subjects who not receiving medical treatment for respiratory diseases.
* Subjects who have clean family medical history.
Exclusion Criteria
* Subjects with respiratory proplems.
* Participation in another clinical trial within the last 30 days.
* Endocrine and metabolic disorders (eg, hypothyroidism, hypercalcemia, diabetes mellitus, diabetes insipidus).
* Neurologic and psychiatric disorders (who can not understand the research project ).
20 Years
29 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Zaytoonah University of Jordan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Saied Zidan
Assistant prof dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed Saied Zidan
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB # 23/3/2024-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.